Ischemic preconditioning is thought to evoke cell survival programs in the heart in large part via the activation of G -protein coupled I receptor signal transduction pathways. However, the identification and characterization of G -protein coupled receptor independent I pathways would enable researchers to pursue novel cellular events that could direct or promote preconditioning. In this regard recent work has begun to explore the role of the innate immune system in intrinsic cardioprotection against both viral myocarditis and ischemia. Interestingly, cytokines such as TNFa, IL-1b and leukemia inhibitory factor, which are components of innate immunity, have been shown to mimic ischemic preconditioning. Thus as the innate immune system functions via a diverse array of G -protein independent receptors, I the study of this immunological system in the heart may provide new insight into mechanisms driving and promoting ischemic preconditioning. We propose that innate immunity is indeed an integral part of ischemic preconditioning. In this review, we provide an overview of the innate immune system, describe the studies whereby cytokines mimic ischemic preconditioning and finally postulate some mechanisms whereby innate immunity may promote cardioprotection as a component of preconditioning. 
. Introduction
CD14 on monocytes, natural killer cells and neutrophils with the subsequent production of tumor necrosis factor Innate immunity is a preprogrammed, nonspecific firstalpha (TNFa) [2, 3] . Although these biological responses of line of defense that is primarily responsible for eliminating innate immunity protect the host from invading pathogens, and / or containing microorganisms at the site of entrance this response may also have detrimental effects. This is into the host (reviewed in Refs. [1, 2] ). Innate immunity is best illustrated where an excessive stimulation of innate classically mediated by myeloid-derived cells that produce immunity by gram-negative bacterial endotoxemia leads to cytokines and activate the complement system in response an augmented production of cytokines and other moleto 'shared molecules' across different pathogens. For cules. This in turn, can result in the septic shock syndrome example, lipopolysaccharide (LPS), which is a shared with hypotension, disseminated intravascular coagulation, molecule in all gram negative bacteria, is a conserved multi-organ failure and even death. The exquisite regula-'molecular pattern' that activates innate immunity. In turn, tory mechanisms that direct these divergent effects of these pathogen-associated molecular patterns bind to innate immunity are being actively explored, but as yet are phylogenetically conserved pattern-recognition receptors not fully characterized [4] . which initiate downstream signaling events. A prototypic
The concept that innate immunity may constitute a example being the binding of LPS to the opsonic receptor component of 'adaptive cardiac biology' is being increasingly recognized [5] . This is illustrated whereby components of the innate immunity program seem to be required to resist infectious (myocarditis) and pressuresystem during bacterial infection [16] . In parallel to overload mediated cardiac decompensation and heart failinducing 'endotoxin tolerance' pathogen-associated molecure [6] [7] [8] . Moreover, this cytoprotective program appears ular patterns such as endotoxin and lipoteichoic acid to be important in protecting the heart against cardiac induce protection against ischemia-reperfusion injury [17-ischemic injury [9, 10] . Interestingly, a biological program 20] . Here, hearts pre-emptively exposed to LPS have been termed ischemic preconditioning is proposed to activate shown to display increased tolerance against infarction and innate / intrinsic cytoprotective programs in the heart. Ispost-ischemic ventricular arrhythmias [17] [18] [19] [20] . These carchemic preconditioning is evoked by a short non-lethal dioprotective effects of LPS have a similar temporal period of ischemia and reperfusion and can result in an pattern to that of ischemic preconditioning with acute and acute cardioprotection lasting for 1-2 h following predelayed temporal phases of cardioprotection. Thus, as conditioning (classical preconditioning) and delayed preprimitive pathogen-associated molecular patterns, such as conditioning which denotes a cardioprotected phenotype LPS has been shown to promote preconditioning-like from 24 to 72 h following preconditioning. The focus of cardiac tolerance, the role of innate immunity in the this review is to evaluate whether a link exists between activation of this cardioprotection is worthy of invesinnate immunity and ischemic preconditioning and to tigation. Innate immunity consists of an exquisitely conpostulate how this first-line of immune activation may trolled auto-regulatory network of cytokines that in turn orchestrate cytoprotective effects in the heart in response activate numerous putative cell-survival programs. The to ischemic preconditioning. apical events that activate innate immunity have been reviewed previously [5] and its proposed activation by ischemia and reperfusion is schematized in Fig. 1 . The 2 . Evidence that innate immune activation evokes review will discuss the literature regarding activation of preconditioning-like cardioprotection the innate immune cytokine network in the context of cardiac ischemia-reperfusion and in ischemic precondiBacterial endotoxin or LPS is the prototypic pathogentioning with a final section on the putative cardioprotective associated molecular pattern that activates innate immunity signaling cascades coupled to this cytokine network. and has been shown to have profound detrimental effects on cardiac contractile function and on myocardial integrity [11] [12] [13] [14] . Interestingly, a preemptive non-lethal exposure to 3 . Toll-like receptors in cardiac ischemia LPS results in a subsequent blunted response to a second LPS challenge [15] . This resilience to the adverse effects Toll-like receptors (TLR) are the pattern-recognition of endotoxemia is termed 'endotoxin tolerance' and is receptors through which extra-cellular pattern-recognition thought to be an adaptive response providing protection molecules (e.g., LPS) direct intracellular signaling events from pathological hyper-activation of the innate immune and the subsequent activation of the innate immunity Fig. 1 . Schematic representation of a hypothetical model depicting early regulation of the innate immune system via ischemic preconditioning. The mechanism whereby ischemia-reperfusion itself upregulates toll-like receptors has not been explored, but could act via the generation of reactive oxygen species. ROS, in turn is known to facilitate the release of NFkB from its cognate cytosolic chaperone resulting in translocation of NFkB to the nucleus and subsequent transactivation of cytokines, for example. TLR5Toll-like receptors.
cytokine cascade. The mammalian TLR proteins derive of intracellular reactive oxygen species [37, 38] . TNFa is their name from the Drosophilia Toll proteins, with which synthesized in myeloid and cardiac tissue in direct rethey share sequence similarity. Currently, two TLR subsponse to cardiac ischemia and reperfusion injury-infarctypes have been described in cardiac tissue and are tion [33] [34] [35] [36] . Whether this pro-inflammatory cytokine is designated TLR 2 and TLR 4 family members [5, 21] .
produced in response to the non-lethal ischemia and Upregulation of Toll-like receptors in the heart have been reperfusion that evokes the preconditioning phenotype is associated with oxidative stress [22] , endotoxin administraless clear. However, suggestive data from Heusch and tion [23] , in response to myocardial ischemia and during colleagues have demonstrated that cardiac ischemic preheart failure [21] . The prototypic activator of innate conditioning does result in a modest induction of serum immunity (LPS) binds to its cognate receptor (CD14) TNFa levels in rabbits [19] . Moreover, in an isolated which in turn is thought to interact with TLRs to activate perfused mouse heart preparation we have recently demontransmembrane signal transduction [2] . Activation of these strated that ischemic preconditioning does evoke an uptransmembrane signaling proteins have, in turn, been regulation of cardiac steady-state TNFa peptide levels associated with the activation of the nuclear regulatory [39] . These data demonstrate an association between factor NFkB. Interestingly, this transcription factor is ischemic preconditioning and TNFa production. thought to play a pivotal role in both the activation of
In our laboratory we have demonstrated that exogenous innate immunity and in the cardioprotection conferred by TNFa administration using a preconditioning-like protocol ischemic preconditioning [24] [25] [26] . However, to date no in the isolated perfused rat heart does mimic classical studies have been published concerning a link between ischemic preconditioning [40] . Moreover, neutralizing CD14, Toll-like receptors and preconditioning. This putaantibodies directed against both TNFa and the cytokine tive biological link is attractive as reactive oxygen species IL-1b abrogate exercise induced preconditioning-like carare proposed activators of Toll-like receptors and are dioprotection in the rat [41] . Finally, in mice genetically concurrently recognized as 'triggers' of preconditioning depleted of TNFa, we have recently demonstrated that cardioprotection [27] [28] [29] [30] .
TNFa is necessary for ischemic preconditioning in the isolated perfused heart and that this cytokine is sufficient to activate this acute cardioprotective phenotype [39] .
. Activation of the cytokine cascade during cardiac
The role of TNFa in delayed preconditioning has also ischemia and reperfusion been firmly established. Here Nelson et al.
[42] demonstrated that pretreatment of rabbits with intravenous TNFa As LPS administration can evoke preconditioning-like 24 h before simulated ischemia and reperfusion, resulted in cardioprotection, the identification of LPS induced cytoimproved cardiac contractile functional recovery and rekines could identify putative cytokines targets that may duced lactate dehydrogenase release. These investigators direct this cardioprotection. In this regard, an in vivo noted that TNFa pretreatment with the resultant reduction challenge with LPS is known to activate the tumor necrosis in ischemia-reperfusion injury, correlated with an increase factor alpha (TNFa), Interleukin-1 (IL-1), Interleukin-6 in myocardial manganese superoxide dismutase (Mn-(IL-6) and intracellular cytokine mediated signaling mole-SOD) activity. The upregulation of the free radical cules and regulatory peptides [31, 32] . Similarly, numerous scavenger is, at least in part, a plausible mechanism investigators have demonstrated endogenous cardiac and whereby TNFa can protect against ischemia and reperfuinfiltrating inflammatory cell production of similar cytosion injury. A role for TNFa in delayed preconditioning kines, i.e. TNFa, IL-1b and IL-6 in response to cardiac has now been confirmed by numerous investigators ischemia and reperfusion [33] [34] [35] [36] . Here investigators have [41, 43, 44] . Interestingly, TNFa mediated upregulation of postulated that this cytokine production may play a role in Mn-SOD is thought to be, in part via transactivation of both reperfusion injury, contractile recovery and in cardiac NFkB [45] , and the activation of NFkB is thought to be remodeling post myocardial infarction. However, as will essential in the activation of the late preconditioning be discussed throughout the duration of this review, these program [25] . cytokines may have an additional function as integral Of note, in classic ischemic preconditioning, the initial factors in the intrinsic cardioprotective program that may ischemic 'trigger' or administration of the preconditioningbe activated by ischemic preconditioning. mimetic adenosine has been shown to attenuate subsequent ischemia-reperfusion associated TNFa production [19, 46] . These experiments suggest that a component of the pre-5 . Pro-inflammatory cytokines activate classical and conditioning 'trigger' attenuate post ischemia-reperfusiondelayed preconditioning induced TNFa production. This putative biphasic regulation of TNFa is consistent with the preconditioning TNFa is an apical pro-inflammatory cytokine in the paradigm, as it is thought that elevated TNFa levels at innate immune system and can be activated in response to reperfusion would be pro-inflammatory and could hence both Toll-like receptor activation [3] and via the generation augment reperfusion damage [47, 48] . Thus a hypothesis that requires testing states that the preconditioning trigger protection was thought to be due to the upregulation of the activates TNFa to putatively promote innate cell survival.
reactive oxygen species (ROS) scavenger manganese In parallel, a putative negative autoregulatory effect of this superoxide dismutase. In addition, the three cardiac enTNFa production could attenuate the subsequent productriched gp130 receptor cytokine ligands have been shown to ion of this proinflammatory cytokine during post-ischemic promote cardiac protection against toxic insults including reperfusion. This hypothesis, if proven, would support the ischemia-reperfusion injury. In brief, pre-incubation of rat concept that transient production of TNFa may promote neonatal cardiomyocytes with LIF conferred protection innate cellular survival pathways. Moreover, this temporal against hypoxia-reoxygenation injury via attenuation of regulation of TNFa biosynthesis would be consistent with ROS production [57] . IL-6, in turn promotes cytoprotecthe exquisite autoregulatory role of the cytokine network in tion of rat neonatal cardiomyocytes against sphingosine directing the appropriate physiologic response to a given mediated apoptosis [9] . Furthermore, CT-1 when adminisbiomechanical stress [4, 49] .
tered as either a pre-treatment or at the time of reoxygena-IL-1b and TNFa are generally thought to be regulated tion has been shown to be cardioprotective against simuin parallel and have synergistic pro-inflammatory and lated ischemia-reoxygenation injury in rat cardiomyocytes chemokine activating effects in myeloid cells. This coacti- [58] . vation is mirrored in cardiac ischemia-reperfusion where
The gp130-receptor signaling is usually mediated via IL-1b is co-expressed with TNFa. However, the role of JAK-STAT transduction pathways [59] . These pathways IL-1b in activating preconditioning has not been as have not been extensively explored in the context of extensively studied as that of TNFa. However, as was ischemic preconditioning; however, Bolli and colleagues alluded to previously, a combination of neutralizing antirecently established that functional JAK-STAT signaling bodies to both IL-1b and to TNFa were required to is essential to induce the delayed preconditioning phenoattenuate the preconditioning phenotype evoked by exertype [60] . Further data implicate the involvement of the cise in rats [41] . Moreover, numerous studies have demon-JAK-STAT system in classical preconditioning, but restrated that the administration or activation of IL-1b does quires additional studies to establish a mechanism [61, 62] . evoke the delayed preconditioning phenotype in the rat
In short, the role of gp130-receptor signaling in preheart [20, 50, 51] .
conditioning has not been extensively investigated. HowCollectively, these data support the role of these two ever, the data presented above suggest that this cytokineapical pro-inflammatory pleiotropic cytokines in the activareceptor linked regulatory system may play a role in tion of the cell survival program mediated by ischemic preconditioning and may provide insight into the activation preconditioning. Recognition that preconditioning can arise of the JAK-STAT signal transduction in ischemic prefrom the activation of pro-inflammatory cytokines should conditioning. now allow molecular and cellular analysis of the specific intracellular signaling cascades downstream of cytokinereceptor interaction that may play a critical role in the 7 . The role of anti-inflammatory cytokines in cardiac development of this tolerant cardiac phenotype. protection
The innate immune system is usually tightly controlled 6 . Glycoprotein-130 receptor mediated by comprehensive autoregulatory mechanisms [63] [64] [65] . cardioprotection For example, the immunosuppressive and anti-inflammatory cytokines such as transforming growth factor b and In addition to the direct activation of cytoprotective interleukin 10 (IL-10) are thought to have evolved to signaling molecules (discussed in Section 8), the procontrol immune reactions and to prevent over-robust inflammatory cytokines TNFa and IL-1b are known to reactions that become destructive to the host. A role for activate numerous mediator cytokines, in part via the immunosuppressive or anti-inflammatory cytokines in the regulatory kinase TAK1 [52, 53] . The glycoprotein 130 attenuation of the pro-inflammatory cytokines during post-(gp130) receptor family of cytokines is known to be ischemic reperfusion would be an equivalent scenario that activated by the apical pro-inflammatory cytokines [9, 54] could result in an adaptive modulation of cytokines during and three members of this family, i.e., leukemia inhibitory cardiac ischemia and reperfusion. To date, this concept has factor (LIF), IL-6 and cardiotrophin-1 (CT-1) are ennot been explored in the context of preconditioning. dogenously synthesized by the heart [55, 56] .
However, the role of IL-10 has been investigated in cardiac The role of gp130 receptor mediated cytokine signaling ischemia and reperfusion. As background, IL-10 which in ischemic preconditioning has not been extensively was first identified as a cytokine synthesis inhibiting factor investigated. However, LIF when administered as a pre- [66] , is a homodimeric cytokine and plays a key role in the conditioning mimetic has been shown to confer delayed regulation of inflammatory and immune responses. The protection against post-ischemic contractile dysfunction anti-inflammatory properties of IL-10 are partially meand cardiac damage in rabbits [42] . Here the mechanism of diated by inhibition of the production of pro-inflammatory cytokines such as IL-1a, IL-1b, IL-6, IL-8 and TNFa from promotion of cardioprotective programs against ischemiathe monocytes, macrophages [67, 68] and neutrophils [69] .
reperfusion injury are proposed to be mediated via PKC Multiple studies have demonstrated IL-10 in the plasma [84] , NFkB [85] and SAPK [86] . Although the data from patients following acute myocardial infarction or supporting a role for IL-1b in preconditioning is less during cardiopulmonary bypass [70] [71] [72] . In mice IL-10 extensive than for TNFa seemingly parallel signaling can levels increase 2-6 h after myocardial reperfusion [73] .
promote the cell survival effects of these two cytokines. This endogenous production of IL-10 appears to be critical Hence in the context of preconditioning, we will briefly in diminishing myocardial injuries after myocardial isreview the IL-1b activated cell survival signaling, although chemia-reperfusion. Using an IL-10 deficient mice model, we should caution that delineation of IL-1b signaling has the same investigators confirmed that the absence of IL-10 been less extensively characterized in the heart. In diverse was associated with a large mortality following ischemiatissue types IL-1b has been shown to activate classical reperfusion [47] . Here, it was suggested that endogenous pro-survival signaling kinases including the phosphatidyl-IL-10 inhibits the production of TNFa and nitric oxide, inositol 3-kinase-Akt pathway [87] and tyrosine kinase and hence serves to protect the ischemia-reperfusion signaling [88] . Moreover, similarly to TNFa, IL-1b actiexposed myocardium through the suppression of neutrophil vates cytoprotective signaling cascades and upregulates recruitment. Moreover, recently Jones et al. confirmed that mediator cytokines such as IL-6 via the activation of deficiency of IL-10 exacerbated myocardial injury after protein kinase TAK1 [89, 90] . Finally, numerous cytoischemia-reperfusion via an infiltration of neutrophils and protective molecules that have been implicated in prepostulated that this cardioprotective effects of IL-10 was conditioning-induced cell survival, such as Bcl , iNOS and 2 independent of the presence or absence of iNOS [74] . Mn-SOD, have been shown to be activated by IL-1b and While a cardioprotective effect of IL-10 has been TNFa [41, 88, 91] . described in acute myocardial infarction, a role of IL-10 in
The IL-6 family of cytokines may bind to their own ischemic preconditioning has not yet been reported. Howligand specific cognate receptor. The ligand-receptor ever, indirect data to support the hypothesis that IL-10 may complex then interacts with gp130, a cell surface signaling participate in ischemic preconditioning includes the fact receptor, which then goes on to signal a host of intracelluthat numerous cellular systems that modulate preconditionlar pathways [92] . Following the activation of the ubiquiting such as adenosine [75] , heat shock proteins [76] and ously expressed gp130, by the cytokine-receptor complex, ROS [77] augment the production of IL-10. Thus, although the gp130 undergoes homo-or hetero-dimerization. Alnot explored, the anti-inflammatory and immunosuppresthough gp130 and its dimerizing partner posess no intrinsic sive regulatory events that control immune activation may tyrosine kinase domain, associated cytoplasmic tyrosine play a role in ischemic preconditioning.
kinases are activated, allowing subsequent modification of transcription factors [92] . The downstream pathways activated by the gp130 complex include Janus kinase (JAKs) 8 . Cardioprotective cell signaling downstream of and several members of the signal transducer and activator cytokine-receptor interaction of transcription (STAT) family [93, 94] . In addition, gp130 signaling is known to activate signaling intermediates that Ischemic preconditioning is classically known to invoke promote cell survival such as the src family of tyrosine the production of G-protein coupled receptor ligands, such kinases, RAS, mitogen activated protein kinases (MAPK) as adenosine, opioids and bradykinin [78] . The signaling and phosphatidylinositol 3-kinase (PI-3 kinase) [57] . intermediates activated by these ligands have been extenFinally, downstream cytoprotective targets of innate sively investigated in the characterization of cytoprotective immune activation in the heart probably overlap concellular events induced by preconditioning (reviewed in siderably with the signaling cascades activated by GRefs. [78, 79] ). The hypothesis that the innate immune protein-coupled receptor signaling in ischemic precondisystem may contribute to the cytoprotective programs tioning. However, novel putative G-protein independent activated by ischemic preconditioning could identify putasignaling events could be identified in the context of innate tive novel signaling events that may be important in this immunity in ischemic preconditioning. Fig. 2 is a cell-survival promoting biological phenomenon. The reschematic model of putative overlapping and novel sigmainder of this review will focus on describing the known naling between classical ischemic preconditioning acticytoprotective programs activated by innate immunity.
vated signaling and those more unique to innate immune The signaling cascades driven by the prototypic proinmediated events. flammatory cytokines TNFa and IL-1b are remarkably similar, despite being initiated via distinct cell surface receptors. These signaling cascades have been reviewed 9 . Conclusions previously [49, [80] [81] [82] [83] and are not discussed extensively in this review. However, cytoprotective pathways downScientific evidence supports a role for at least three stream of the TNFa receptors that may be relevant to the distinct cytokines, i.e., TNFa, IL-1b and leukemia inhib- itory factor, in ischemic preconditioning. These cytokines the innate immune system needs to be vigorously explored injury.
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